clinical trials

IntraBio Expands Niemann-Pick Trial to ID Neuroprotective, Disease-Modifying Effects
IntraBio Expands Niemann-Pick Trial to ID Neuroprotective, Disease-Modifying Effects
BioSpace
IntraBio
clinical trials
IB1001
Niemann-Pick disease
Flag link:
Novavax to Start Phase III COVID-19 Trials in U.S. with Fast Track Designation
Novavax to Start Phase III COVID-19 Trials in U.S. with Fast Track Designation
BioSpace
Novavax
clinical trials
vaccines
COVID-19
fast track
FDA
Flag link:
Arena's lead drug misses on PhII in AD, thwacking stock, but company soldiers on into Phase III
Arena's lead drug misses on PhII in AD, thwacking stock, but company soldiers on into Phase III
Endpoints
Arena Pharmaceuticals
etrasimod
clinical trials
atopic dermatitis
Flag link:
FDA lays out strategies for promoting diversity in clinical trial enrollment
FDA lays out strategies for promoting diversity in clinical trial enrollment
RAPS.org
FDA
clinical trials
diversity
clinical trial diversity
Flag link:
5 takeaways from the FDA's high-stakes meeting for Biogen's Alzheimer's drug
5 takeaways from the FDA's high-stakes meeting for Biogen's Alzheimer's drug
BioPharma Dive
Biogen
FDA
Alzheimer's disease
aducanumab
clinical trials
amyloid
Flag link:
After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
Fierce Pharma
Pfizer
BioNTech
Gilead Sciences
Eli Lilly
Regeneron
COVID-19
pharma stocks
vaccines
clinical trials
Flag link:
Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study
Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study
Bloomberg
Pfizer
BioNTech
vaccines
COVID-19
clinical trials
Flag link:
Zimmer Biomet shares early data on Apple Watch app for recovery after knee surgery
Zimmer Biomet shares early data on Apple Watch app for recovery after knee surgery
MedCity News
Zimmer Biomet
devices
MyMobility
knee surgery
clinical trials
digital health
Apple Watch
Flag link:
First patient dosed with AgenTus’ cell therapy designed to clear COVID-19 virus while reducing inflammation
First patient dosed with AgenTus’ cell therapy designed to clear COVID-19 virus while reducing inflammation
Biopharma Reporter
Agenus
cell therapy
agenT-797
COVID-19
clinical trials
Flag link:
Assembly Bio's hepatitis B program flops as a potential cure in PhII, sending shares spiraling
Assembly Bio's hepatitis B program flops as a potential cure in PhII, sending shares spiraling
Endpoints
Assembly Biosciences
hepatitis B
clinical trials
vebicorvir
Flag link:
Novartis’ Ilaris fails in late-stage COVID-19 trial
Novartis’ Ilaris fails in late-stage COVID-19 trial
Pharmaforum
Novartis
Ilaris
COVID-19
clinical trials
Flag link:
Astra aims for “the Trump setting”
Astra aims for “the Trump setting”
EP Vantage
AstraZeneca
COVID-19
antibodies
clinical trials
Flag link:
Trial chief tips AstraZeneca COVID-19 vaccine for 2020 data drop
Trial chief tips AstraZeneca COVID-19 vaccine for 2020 data drop
Fierce Biotech
AstraZeneca
clinical trials
AZD1222
vaccines
COVID-19
Flag link:
Novartis’ Aimovig tops topiramate in migraine face-off
Novartis’ Aimovig tops topiramate in migraine face-off
Pharmaforum
Novartis
Aimovig
Topiramate
migraines
clinical trials
Flag link:
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Pharmaceutical Business Review
Ionis Pharmaceuticals
Akcea Therapeutics
Pfizer
clinical trials
vupanorsen
cholesterol
Flag link:
Aptevo’s Phase I APVO436 Trial on Right Track Against AML
Aptevo’s Phase I APVO436 Trial on Right Track Against AML
BioSpace
Aptevo
APVO436
immunotherapy
AML
clinical trials
Flag link:
Neuraly gets FDA clearance of INDA to initiate phase 2b trial of NLY01 in Alzheimer’s Disease
Neuraly gets FDA clearance of INDA to initiate phase 2b trial of NLY01 in Alzheimer’s Disease
Pharmaceutical Business Review
Neuraly
NLY01
clinical trials
Alzheimer's disease
Flag link:
J&J plans to test its COVID-19 vaccine in ages 12-18 soon
J&J plans to test its COVID-19 vaccine in ages 12-18 soon
Reuters
JNJ
vaccines
COVID-19
clinical trials
Flag link:
Novavax expands in Maryland as it gears up for late-stage COVID vaccine trial in the U.S.
Novavax expands in Maryland as it gears up for late-stage COVID vaccine trial in the U.S.
Fierce Pharma
Novavax
vaccines
COVID-19
clinical trials
Flag link:
A little biotech's second crack at dry eye disease comes up short. And this time there will be no extra shot at success
A little biotech's second crack at dry eye disease comes up short. And this time there will be no extra shot at success
Endpoints
Aurinia Pharmaceuticals
VOS
dry eye disease
clinical trials
Flag link:

Pages